Mary Reumuth | Chief Financial Officer |
Mark Iwicki | Chairman, President and Chief Executive Officer |
Todd Bazemore | Chief Operating Officer |
Kim Brazzell | Chief Medical Officer |
Hongming Chen | Chief Scientific Officer |
Shveta Vilas | Wedbush |
Esther Rajavelu | Oppenheimer |
Yi Chen | H.C. Wainwright |
Good morning, and welcome to Kala Pharmaceuticals First Quarter 2019 Earnings Conference Call. At this time, all participants are in a listen-only mode.
Following management’s prepared remarks, a Question-and-Answer Session will be held. And as a reminder, this call is being recorded.
As a reminder, this call is being recorded.